Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 2a, Randomized, Double-blind, Placebo-controlled, Multiple-dose, 2-Part Study to Assess the Safety, Tolerability and Pharmacokinetic Response and Explore the Pharmacodynamic Response Following 4 Weeks of Once Weekly Subcutaneous Injections of PB1046 in Adult Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF) (Part 1) and in Subjects With Cardiac Dysfunction Secondary to Duchenne Muscular Dystrophy (Part 2)
Status: Enrolling
Updated:  12/31/1969
Cardiology Associates Research Company
mi
from
Daytona Beach, FL
Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 2a, Randomized, Double-blind, Placebo-controlled, Multiple-dose, 2-Part Study to Assess the Safety, Tolerability and Pharmacokinetic Response and Explore the Pharmacodynamic Response Following 4 Weeks of Once Weekly Subcutaneous Injections of PB1046 in Adult Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF) (Part 1) and in Subjects With Cardiac Dysfunction Secondary to Duchenne Muscular Dystrophy (Part 2)
Status: Enrolling
Updated: 12/31/1969
Cardiology Associates Research Company
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 2a, Randomized, Double-blind, Placebo-controlled, Multiple-dose, 2-Part Study to Assess the Safety, Tolerability and Pharmacokinetic Response and Explore the Pharmacodynamic Response Following 4 Weeks of Once Weekly Subcutaneous Injections of PB1046 in Adult Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF) (Part 1) and in Subjects With Cardiac Dysfunction Secondary to Duchenne Muscular Dystrophy (Part 2)
Status: Enrolling
Updated:  12/31/1969
Revivial Research
mi
from
Miami, FL
Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 2a, Randomized, Double-blind, Placebo-controlled, Multiple-dose, 2-Part Study to Assess the Safety, Tolerability and Pharmacokinetic Response and Explore the Pharmacodynamic Response Following 4 Weeks of Once Weekly Subcutaneous Injections of PB1046 in Adult Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF) (Part 1) and in Subjects With Cardiac Dysfunction Secondary to Duchenne Muscular Dystrophy (Part 2)
Status: Enrolling
Updated: 12/31/1969
Revivial Research
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 2a, Randomized, Double-blind, Placebo-controlled, Multiple-dose, 2-Part Study to Assess the Safety, Tolerability and Pharmacokinetic Response and Explore the Pharmacodynamic Response Following 4 Weeks of Once Weekly Subcutaneous Injections of PB1046 in Adult Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF) (Part 1) and in Subjects With Cardiac Dysfunction Secondary to Duchenne Muscular Dystrophy (Part 2)
Status: Enrolling
Updated:  12/31/1969
North Dallas Research Associates
mi
from
McKinney, TX
Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 2a, Randomized, Double-blind, Placebo-controlled, Multiple-dose, 2-Part Study to Assess the Safety, Tolerability and Pharmacokinetic Response and Explore the Pharmacodynamic Response Following 4 Weeks of Once Weekly Subcutaneous Injections of PB1046 in Adult Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF) (Part 1) and in Subjects With Cardiac Dysfunction Secondary to Duchenne Muscular Dystrophy (Part 2)
Status: Enrolling
Updated: 12/31/1969
North Dallas Research Associates
mi
from
McKinney, TX
Click here to add this to my saved trials
Imaging Study of Lead Implant for His Bundle Pacing
Imagining Study of Lead Implant for His Bundle Pacing
Status: Enrolling
Updated:  12/31/1969
Indiana University / Krannert Institute of Cardiology
mi
from
Indianapolis, IN
Imaging Study of Lead Implant for His Bundle Pacing
Imagining Study of Lead Implant for His Bundle Pacing
Status: Enrolling
Updated: 12/31/1969
Indiana University / Krannert Institute of Cardiology
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Imaging Study of Lead Implant for His Bundle Pacing
Imagining Study of Lead Implant for His Bundle Pacing
Status: Enrolling
Updated:  12/31/1969
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Imaging Study of Lead Implant for His Bundle Pacing
Imagining Study of Lead Implant for His Bundle Pacing
Status: Enrolling
Updated: 12/31/1969
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Imaging Study of Lead Implant for His Bundle Pacing
Imagining Study of Lead Implant for His Bundle Pacing
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University Health System
mi
from
Richmond, VA
Imaging Study of Lead Implant for His Bundle Pacing
Imagining Study of Lead Implant for His Bundle Pacing
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University Health System
mi
from
Richmond, VA
Click here to add this to my saved trials
Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10
A Phase 1 Randomized, Placebo-controlled, Single and Multiple Ascending Dose Study of the Tolerability, Pharmacokinetics and Pharmacodynamics of AG10 in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Celerion
mi
from
Tempe, AZ
Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10
A Phase 1 Randomized, Placebo-controlled, Single and Multiple Ascending Dose Study of the Tolerability, Pharmacokinetics and Pharmacodynamics of AG10 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Status: Enrolling
Updated:  12/31/1969
Ocular Immunology and Uveitis Foundation
mi
from
Waltham, MA
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Status: Enrolling
Updated: 12/31/1969
Ocular Immunology and Uveitis Foundation
mi
from
Waltham, MA
Click here to add this to my saved trials
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
A Patient and Investigator-blinded, Randomized, Placebo Controlled Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Jacksonville, FL
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
A Patient and Investigator-blinded, Randomized, Placebo Controlled Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
A Patient and Investigator-blinded, Randomized, Placebo Controlled Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
A Patient and Investigator-blinded, Randomized, Placebo Controlled Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
A Patient and Investigator-blinded, Randomized, Placebo Controlled Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Kiel,
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
A Patient and Investigator-blinded, Randomized, Placebo Controlled Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Kiel,
Click here to add this to my saved trials
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center - Princeton
mi
from
Birmingham, AL
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center - Princeton
mi
from
Birmingham, AL
Click here to add this to my saved trials
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated:  12/31/1969
Cardiology Associates of North East Arkansas
mi
from
Jonesboro, AR
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated: 12/31/1969
Cardiology Associates of North East Arkansas
mi
from
Jonesboro, AR
Click here to add this to my saved trials
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated:  12/31/1969
Arkansas Cardiology, PA
mi
from
Little Rock, AR
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated: 12/31/1969
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Click here to add this to my saved trials
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated:  12/31/1969
Bethesda Memorial Hospital
mi
from
Boynton Beach, FL
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated: 12/31/1969
Bethesda Memorial Hospital
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated:  12/31/1969
Bryan LGH Medical Center East
mi
from
Lincoln, NE
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated: 12/31/1969
Bryan LGH Medical Center East
mi
from
Lincoln, NE
Click here to add this to my saved trials
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated:  12/31/1969
Aurora Medical Group
mi
from
Milwaukee, WI
EnSite Precision Observational Study
A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World Environment
Status: Enrolling
Updated: 12/31/1969
Aurora Medical Group
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban
Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban
Status: Enrolling
Updated:  12/31/1969
US database
mi
from
New York, NY
Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban
Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban
Status: Enrolling
Updated: 12/31/1969
US database
mi
from
New York, NY
Click here to add this to my saved trials
Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform
Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform (iMAWDS Mobile HF Study)
Status: Enrolling
Updated:  12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform
Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform (iMAWDS Mobile HF Study)
Status: Enrolling
Updated: 12/31/1969
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Proof-of-Concept Study of Heart Habits Application for Patients With Heart Failure
Proof-of-Concept Study of a Smartphone Application Created to Improve Management of Ambulatory Patients With Heart Failure: the Heart Failure Heart Habits Application
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Proof-of-Concept Study of Heart Habits Application for Patients With Heart Failure
Proof-of-Concept Study of a Smartphone Application Created to Improve Management of Ambulatory Patients With Heart Failure: the Heart Failure Heart Habits Application
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Saint Louis University Hospital
mi
from
Saint Louis, MO
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Saint Louis University Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Duke University
mi
from
Durham, NC
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Metro Health System
mi
from
Cleveland, OH
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Metro Health System
mi
from
Cleveland, OH
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvaina
mi
from
Philadelphia, PA
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvaina
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated:  12/31/1969
University of Vermont
mi
from
Burlington, VT
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Status: Enrolling
Updated: 12/31/1969
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Status: Enrolling
Updated:  12/31/1969
Lancaster General Heatlh / Penn Medicine
mi
from
Lancaster, PA
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
Status: Enrolling
Updated: 12/31/1969
Lancaster General Heatlh / Penn Medicine
mi
from
Lancaster, PA
Click here to add this to my saved trials
CHF Inpatient Ambulation Trial
CHF Inpatient Ambulation Trial
Status: Enrolling
Updated:  12/31/1969
Lancaster General Hospital
mi
from
Lancaster, PA
CHF Inpatient Ambulation Trial
CHF Inpatient Ambulation Trial
Status: Enrolling
Updated: 12/31/1969
Lancaster General Hospital
mi
from
Lancaster, PA
Click here to add this to my saved trials
Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient
Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient
Status: Enrolling
Updated:  12/31/1969
Shriners Hospitals for Children
mi
from
Cincinnati, OH
Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient
Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient
Status: Enrolling
Updated: 12/31/1969
Shriners Hospitals for Children
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Remote Ischemic Preconditioning for Carotid Endarterectomy
Remote Ischemic Preconditioning for Carotid Endarterectomy
Status: Enrolling
Updated:  12/31/1969
UPMC
mi
from
Pittsburgh, PA
Remote Ischemic Preconditioning for Carotid Endarterectomy
Remote Ischemic Preconditioning for Carotid Endarterectomy
Status: Enrolling
Updated: 12/31/1969
UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Short-Term Endogenous Hydrogen Sulfide Upregulation
Short-Term Endogenous Hydrogen Sulfide Upregulation
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Short-Term Endogenous Hydrogen Sulfide Upregulation
Short-Term Endogenous Hydrogen Sulfide Upregulation
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigator Site
mi
from
Chicago, IL
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Detroit, MI
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Cleveland, OH
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Philadelphia, PA
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Saint Louis, MO
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Houston, TX
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Tacoma, WA
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Aalst,
A Study of CLR325 in Chronic Stable Heart Failure Patients.
A Randomized, Subject and Investigator-blind, Placebo-controlled Study of CLR325 in Chronic Stable Heart Failure Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Aalst,
Click here to add this to my saved trials